Onyx Pharmaceuticals

Active

Updated: Apr 2, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jun 16, 2015	Kezar Life Sciences	$23.0M Series A	—	9W Capital Management, AJU IB Investment, Cormorant Asset Management, EcoR1 Capital, Morningside, Omega Funds

Total Raised

N/A

Valuation

N/A